A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies
- 1 April 2007
- journal article
- Published by Elsevier BV in Journal of Nuclear Cardiology
- Vol. 14 (2), 215-220
- https://doi.org/10.1016/j.nuclcard.2006.10.022
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failureJournal of Nuclear Cardiology, 2006
- Oxidative Stress Mediates Tumor Necrosis Factor-α–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac MyocytesCirculation, 2003
- Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failureJournal of the American College of Cardiology, 2003
- Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and TI-201 SPECT imagingAnnals of Nuclear Medicine, 2001
- Mitochondrial DNA Mutations and Mitochondrial Abnormalities in Dilated CardiomyopathyThe American Journal of Pathology, 1998
- Characterization of Phosphine Complexes of Technetium(III) as Transport Substrates of the Multidrug Resistance P-Glycoprotein and Functional Markers of P-Glycoprotein at the Blood−Brain BarrierBiochemistry, 1997
- Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion.Circulation, 1992
- Physiological basis of myocardial perfusion imaging with the technetium 99m agentsSeminars in Nuclear Medicine, 1991
- Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.Circulation, 1990
- Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile.Circulation, 1988